{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:07:04Z","timestamp":1761512824924,"version":"3.44.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.amjmed.2009.12.022","type":"journal-article","created":{"date-parts":[[2010,6,24]],"date-time":"2010-06-24T04:54:45Z","timestamp":1277355285000},"page":"658.e1-658.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Department-related Tasks and Organ-targeted Therapy in Fabry Disease: An Interdisciplinary Challenge"],"prefix":"10.1016","volume":"123","author":[{"given":"Frank","family":"Weidemann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Sommer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Duning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ines","family":"Lanzl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"M\u00f6hrenschlager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis","family":"Naleschinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathrin","family":"Arning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Baron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Niemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Breunig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Strotmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Wanner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2009.12.022_bib1","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-138-4-200302180-00014","article-title":"Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy","volume":"138","author":"Desnick","year":"2003","journal-title":"Ann Intern Med"},{"issue":"Suppl A","key":"10.1016\/j.amjmed.2009.12.022_bib2","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S0149-2918(07)80115-9","article-title":"Fabry disease model: a rational approach to the management of Fabry disease","volume":"29","author":"Wanner","year":"2007","journal-title":"Clin Ther"},{"key":"10.1016\/j.amjmed.2009.12.022_bib3","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","article-title":"Enzyme replacement therapy in Fabry disease: a randomized controlled trial","volume":"285","author":"Schiffmann","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2009.12.022_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"Safety and efficacy of recombinant human alpha-galactosidase A\u2014replacement therapy in Fabry's disease","volume":"345","author":"Eng","year":"2001","journal-title":"N Engl J Med"},{"issue":"1-2","key":"10.1016\/j.amjmed.2009.12.022_bib5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.pain.2009.07.025","article-title":"Fabry disease\u2014pain doctors have to find the missing ones","volume":"145","author":"Naleschinski","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.amjmed.2009.12.022_bib6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.7326\/0003-4819-146-2-200701160-00148","article-title":"Agalsidase-beta therapy for advanced Fabry disease: a randomized trial","volume":"146","author":"Banikazemi","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjmed.2009.12.022_bib7","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/eurheartj\/ehi143","article-title":"The variation of morphological and functional cardiac manifestation in Fabry disease: potential implications for the time course of the disease","volume":"26","author":"Weidemann","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjmed.2009.12.022_bib8","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/hrt.2005.063818","article-title":"The heart in Anderson-Fabry disease and other lysosomal storage disorders","volume":"93","author":"Linhart","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.amjmed.2009.12.022_bib9","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/S0735-1097(02)02380-X","article-title":"Cardiac manifestations of Anderson-Fabry disease in heterozygous females","volume":"40","author":"Kampmann","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjmed.2009.12.022_bib10","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/j.jacc.2007.06.062","article-title":"Prevalence of Fabry disease in a cohort of 508 unrelated patients with hypertrophic cardiomyopathy","volume":"50","author":"Monserrat","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjmed.2009.12.022_bib11","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1007\/s00392-002-0870-7","article-title":"Fabry disease in patients with hypertrophic cardiomyopathy (HCM)","volume":"91","author":"Beer","year":"2002","journal-title":"Z Kardiol"},{"key":"10.1016\/j.amjmed.2009.12.022_bib12","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1056\/NEJM199508033330504","article-title":"An atypical variant of Fabry's disease in men with left ventricular hypertrophy","volume":"333","author":"Nakao","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2009.12.022_bib13","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/j.ehj.2003.09.017","article-title":"Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease","volume":"24","author":"Moon","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjmed.2009.12.022_bib14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2362.2008.01921.x","article-title":"Misleading terms in Anderson-Fabry disease","volume":"38","author":"Weidemann","year":"2008","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.amjmed.2009.12.022_bib15","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1161\/01.CIR.0000091253.71282.04","article-title":"Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study","volume":"108","author":"Weidemann","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.amjmed.2009.12.022_bib16","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1161\/01.CIR.0000061952.27445.A0","article-title":"Early detection of Fabry cardiomyopathy by tissue Doppler imaging","volume":"107","author":"Pieroni","year":"2003","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.amjmed.2009.12.022_bib17","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.amjcard.2005.05.033","article-title":"Prevalence and clinical significance of cardiac arrhythmia in Anderson-Fabry disease","volume":"96","author":"Shah","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjmed.2009.12.022_bib18","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jjcc.2007.12.001","article-title":"Terminal stage cardiac findings in patients with cardiac Fabry disease: an electrocardiographic, echocardiographic, and autopsy study","volume":"51","author":"Takenaka","year":"2008","journal-title":"J Cardiol"},{"issue":"10","key":"10.1016\/j.amjmed.2009.12.022_bib19","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.amjcard.2005.11.087","article-title":"Impact of enzyme replacement therapy on cardiac morphology and function and late enhancement in Fabry's cardiomyopathy","volume":"97","author":"Beer","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjmed.2009.12.022_bib20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/hrt.2006.104026","article-title":"Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa","volume":"94","author":"Hughes","year":"2008","journal-title":"Heart"},{"key":"10.1016\/j.amjmed.2009.12.022_bib21","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1161\/CIRCULATIONAHA.105.170073","volume":"112","author":"Radford","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.amjmed.2009.12.022_bib22","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1093\/ndt\/gfm848","article-title":"Nephropathy in males and females with Fabry disease: cross-sectional description of patients before treatment with enzyme replacement therapy","volume":"23","author":"Ortiz","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.amjmed.2009.12.022_bib23","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1038\/sj.ki.5001794","article-title":"Predicting initiation and progression of chronic kidney disease: developing renal risk scores","volume":"70","author":"Taal","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.amjmed.2009.12.022_bib24","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1097\/01.ASN.0000124671.61963.1E","article-title":"Results of a nationwide screening for Anderson-Fabry disease among dialysis patients","volume":"15","author":"Kotanko","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.amjmed.2009.12.022_bib25","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1046\/j.1523-1755.2003.00160.x","article-title":"Fabry disease: detection of undiagnosed hemodialysis patients and identification of a \u201crenal variant\u201d phenotype","volume":"64","author":"Nakao","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.amjmed.2009.12.022_bib26","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/01.gim.0000237866.70357.c6","article-title":"Fabry disease: guidelines for the evaluation and management of multi-organ system involvement","volume":"8","author":"Eng","year":"2006","journal-title":"Genet Med"},{"key":"10.1016\/j.amjmed.2009.12.022_bib27","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1056\/NEJMcp011773","article-title":"Clinical practice","volume":"346","author":"Remuzzi","year":"2002","journal-title":"N Engl J Med"},{"issue":"Suppl A","key":"10.1016\/j.amjmed.2009.12.022_bib28","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S0149-2918(07)80118-4","article-title":"Stroke and brain structural alterations in Fabry disease","volume":"29","author":"Fellgiebel","year":"2007","journal-title":"Clin Ther"},{"key":"10.1016\/j.amjmed.2009.12.022_bib29","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1161\/STROKEAHA.108.526293","article-title":"Stroke in Fabry disease frequently occurs before diagnosis and in the absence of other clinical events: natural history data from the Fabry Registry","volume":"40","author":"Sims","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.amjmed.2009.12.022_bib30","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S1474-4422(06)70548-8","article-title":"CNS manifestations of Fabry's disease","volume":"5","author":"Fellgiebel","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.amjmed.2009.12.022_bib31","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1212\/WNL.50.6.1746","article-title":"Quantitative analysis of cerebral vasculopathy in patients with Fabry disease","volume":"50","author":"Crutchfield","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.amjmed.2009.12.022_bib32","first-page":"1096","article-title":"Increased signal intensity in the pulvinar on T1-weighted images: a pathognomonic MR imaging sign of Fabry disease","volume":"24","author":"Moore","year":"2003","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.amjmed.2009.12.022_bib33","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1007\/s00415-006-0118-y","article-title":"Pattern of microstructural brain tissue alterations in Fabry disease: a diffusion-tensor imaging study","volume":"253","author":"Fellgiebel","year":"2006","journal-title":"J Neurol"},{"issue":"455","key":"10.1016\/j.amjmed.2009.12.022_bib34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1651-2227.2007.00203.x","article-title":"Quantification of brain tissue alterations in Fabry disease using diffusion-tensor imaging","volume":"96","author":"Fellgiebel","year":"2007","journal-title":"Acta Paediatr Suppl"},{"key":"10.1016\/j.amjmed.2009.12.022_bib35","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1136\/jnnp.2006.112987","article-title":"Voxel based analyses of diffusion tensor imaging in Fabry disease","volume":"78","author":"Albrecht","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"457","key":"10.1016\/j.amjmed.2009.12.022_bib36","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1651-2227.2008.00658.x","article-title":"Fabry disease during childhood: clinical manifestations and treatment with agalsidase alfa","volume":"97","author":"Ramaswami","year":"2008","journal-title":"Acta Paediatr Suppl"},{"key":"10.1016\/j.amjmed.2009.12.022_bib37","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/mus.10181","article-title":"Small-fiber neuropathy","volume":"26","author":"Lacomis","year":"2002","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.amjmed.2009.12.022_bib38","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/j.1526-4637.2008.00470.x","article-title":"Detection of a characteristic painful neuropathy in Fabry disease: a pilot study","volume":"9","author":"Maag","year":"2008","journal-title":"Pain Med"},{"key":"10.1016\/j.amjmed.2009.12.022_bib39","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.pain.2006.01.041","article-title":"Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values","volume":"123","author":"Rolke","year":"2006","journal-title":"Pain"},{"issue":"439","key":"10.1016\/j.amjmed.2009.12.022_bib40","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1651-2227.2002.tb03108.x","article-title":"Evaluation of peripheral and autonomic nerve function in Fabry disease","volume":"91","author":"Hilz","year":"2002","journal-title":"Acta Paediatr Suppl"},{"key":"10.1016\/j.amjmed.2009.12.022_bib41","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/00004691-200212000-00011","article-title":"Small fiber dysfunction predominates in Fabry neuropathy","volume":"19","author":"Dutsch","year":"2002","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.amjmed.2009.12.022_bib42","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/mus.10236","article-title":"Physiological characterization of neuropathy in Fabry's disease","volume":"26","author":"Luciano","year":"2002","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.amjmed.2009.12.022_bib43","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1529-8027.2009.00227.x","article-title":"Autonomic skin responses in females with Fabry disease","volume":"14","author":"Moller","year":"2009","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.amjmed.2009.12.022_bib44","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF02291231","article-title":"Possible mechanism of anhidrosis in a symptomatic female carrier of Fabry's disease: an assessment by skin sympathetic nerve activity and sympathetic skin response","volume":"6","author":"Yamamoto","year":"1996","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.amjmed.2009.12.022_bib45","doi-asserted-by":"crossref","first-page":"682","DOI":"10.2169\/internalmedicine.31.682","article-title":"Fabry's disease","volume":"31","author":"Kato","year":"1992","journal-title":"Intern Med"},{"issue":"5 Pt 2","key":"10.1016\/j.amjmed.2009.12.022_bib46","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0190-9622(87)70274-6","article-title":"Generalized anhidrosis associated with Fabry's disease","volume":"17","author":"Kang","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.amjmed.2009.12.022_bib47","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s10545-007-0521-2","article-title":"Fabry disease: baseline medical characteristics of a cohort of 1765 males and females in the Fabry Registry","volume":"30","author":"Eng","year":"2007","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.amjmed.2009.12.022_bib48","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/mus.10497","article-title":"Enzyme replacement therapy improves peripheral nerve and sweat function in Fabry disease","volume":"28","author":"Schiffmann","year":"2003","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.amjmed.2009.12.022_bib49","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1212\/01.WNL.0000118207.84514.40","article-title":"Enzyme replacement therapy improves function of C-, Adelta-, and Abeta-nerve fibers in Fabry neuropathy","volume":"62","author":"Hilz","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.amjmed.2009.12.022_bib50","series-title":"Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie, 4","article-title":"Diagnostik und Therapie neuropathischer Schmerzen","author":"Baron","year":"2008"},{"key":"10.1016\/j.amjmed.2009.12.022_bib51","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1212\/WNL.23.8.871","article-title":"Relief of pain of Fabry's disease by diphenylhydantoin","volume":"23","author":"Lockman","year":"1973","journal-title":"Neurology"},{"key":"10.1016\/j.amjmed.2009.12.022_bib52","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/0887-8994(95)00007-3","article-title":"Successful treatment of painful crises of Fabry disease with low dose morphine","volume":"12","author":"Gordon","year":"1995","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.amjmed.2009.12.022_bib53","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ymgme.2005.04.009","article-title":"Gastrointestinal manifestations of Fabry disease: clinical response to enzyme replacement therapy","volume":"85","author":"Banikazemi","year":"2005","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.amjmed.2009.12.022_bib54","first-page":"1001","article-title":"Ocular manifestations in various congenital errors of metabolism (homocystinuria, Fabry's glycolipidosis)","volume":"67","author":"Francois","year":"1967","journal-title":"Bull Soc Ophtalmol Fr"},{"key":"10.1016\/j.amjmed.2009.12.022_bib55","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1001\/archopht.1979.01020010327008","article-title":"The ocular manifestations in Fabry's disease","volume":"97","author":"Sher","year":"1979","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.amjmed.2009.12.022_bib56","first-page":"28","article-title":"Chewing gum as aid in treatment of hyposalivation","volume":"57","author":"Odusola","year":"1991","journal-title":"N Y State Dent J"},{"key":"10.1016\/j.amjmed.2009.12.022_bib57","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1046\/j.1525-1470.2003.20326_5.x","article-title":"Options in the treatment of Fabry disease","volume":"20","author":"M\u00f6hrenschlager","year":"2003","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.amjmed.2009.12.022_bib58","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1001\/jama.286.11.1315","article-title":"Skin manifestations of Fabry disease","volume":"286","author":"M\u00f6hrenschlager","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2009.12.022_bib59","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2340\/0001555573133135","article-title":"Angiokeratomas in Fabry's disease and Fordyce's disease: successful treatment with copper vapour laser","volume":"73","author":"Lapins","year":"1993","journal-title":"Acta Derm Venereol"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934310001324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934310001324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:54:02Z","timestamp":1757580842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934310001324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":59,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0002934310001324"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2009.12.022","relation":{},"ISSN":["0002-9343"],"issn-type":[{"type":"print","value":"0002-9343"}],"subject":[],"published":{"date-parts":[[2010,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Department-related Tasks and Organ-targeted Therapy in Fabry Disease: An Interdisciplinary Challenge","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2009.12.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}